Acorda Therapeutics (ACOR) Stock Moves -0.11%: What You Should Know

- Advertisement -
- Advertisement -
- Advertisement -
- Advertisement -

Acorda Therapeutics (ACOR) closed at $0.93 in the latest trading session, marking a -0.11% move from the prior day. This move was narrower than the S&P 500’s daily loss of 0.16%. Meanwhile, the Dow lost 0.12%, and the Nasdaq, a tech-heavy index, lost 0.33%.

Prior to today’s trading, shares of the drugmaker had lost 10.58% over the past month. This has lagged the Medical sector’s loss of 8.16% and the S&P 500’s loss of 10.5% in that time.

ACOR will be looking to display strength as it nears its next earnings release. In that report, analysts expect ACOR to post earnings of -$0.35 per share. This would mark year-over-year growth of 37.5%. Meanwhile, the Zacks Consensus Estimate for revenue is projecting net sales of $39.34 million, down 10.87% from the year-ago period.

For the full year, our Zacks Consensus Estimates are projecting earnings of -$1.03 per share and revenue of $137.11 million, which would represent changes of +40.12% and -28.74%, respectively, from the prior year.

Investors might also notice recent changes to analyst estimates for ACOR. These revisions help to show the ever-changing nature of near-term business trends. As such, positive estimate revisions reflect analyst optimism about the company’s business and profitability.

Our research shows that these estimate changes are directly correlated with near-term stock prices. We developed the Zacks Rank to capitalize on this phenomenon. Our system takes these estimate changes into account and delivers a clear, actionable rating model.

Home of Science
Follow me

- Advertisement -

Discover

Sponsor

Latest

Jamie Dimon says under ‘extremely adverse’ scenario, JPMorgan might consider suspending dividend

KEY POINTS Jamie Dimon said that in a “extremely adverse” downturn in the U.S. economy, JPMorgan Chase would probably consider suspending its dividend to...

Help Your Child Learn Science

You will find in this article a few things that you need to know about science. You may be wondering what the best time...

Vush Is The Next Big Beauty Brand For Women

I know what you’re thinking, “What? Beauty Industry + Sex Toys?” -  3 Years ago this would have been a frowned upon alignment, but...

A Business Plan Template Will Help You

A Business Plan Template Will Help YouBusiness plans are an essential part of any business, and a successful business requires a lot of...

Oil Industry Joins The Fight Against Coronavirus

entilators from Tesla (TSLA). Hand sanitizer from Anheuser Busch and fellow distillers. Face masks from General Motors. It sounds like something out of a...
Home of Science
Follow me